Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Olaparib + Abiraterone for Prostate Cancer
Recruiting1 awardPhase 3
Detroit, Michigan
This trial is testing the combination of olaparib and abiraterone versus placebo and abiraterone to see if it is more effective and has fewer side effects in patients with mCRPC who have not received prior chemotherapy or NHAs.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.